NYSE:DHR.PRA

Stock Analysis Report

Executive Summary

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

Snowflake

Fundamentals

Adequate balance sheet with moderate growth potential.


Similar Companies

Share Price & News

How has Danaher's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.2%

DHR.PRA

1.1%

US Medical Equipment

-0.6%

US Market


1 Year Return

n/a

DHR.PRA

9.9%

US Medical Equipment

0.6%

US Market

No trading data on DHR.PRA.

No trading data on DHR.PRA.


Share holder returns

DHR.PRAIndustryMarket
7 Day3.2%1.1%-0.6%
30 Day5.0%0.6%2.2%
90 Day5.0%2.9%1.1%
1 Yearn/a10.8%9.9%2.9%0.6%
3 Yearn/a70.1%64.9%44.6%35.2%
5 Yearn/a138.9%111.8%61.9%44.2%

Price Volatility Vs. Market

How volatile is Danaher's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Danaher undervalued based on future cash flows and its price relative to the stock market?

42.34x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Danaher's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Danaher's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Danaher is good value based on earnings compared to the US Medical Equipment industry average.

Danaher is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Danaher is poor value based on expected growth next year.


Price Based on Value of Assets

Danaher is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Danaher expected to perform in the next 1 to 3 years based on estimates from 18 analysts?

16.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Danaher's revenue is expected to grow by 8.1% yearly, however this is not considered high growth (20% yearly).

Danaher's earnings are expected to grow by 16.2% yearly, however this is not considered high growth (20% yearly).

Danaher's revenue growth is expected to exceed the United States of America market average.

Danaher's earnings growth is expected to exceed the United States of America market average.

Danaher's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Danaher is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Danaher performed over the past 5 years?

4.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Danaher's year on year earnings growth rate has been positive over the past 5 years.

Danaher's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Danaher's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

Danaher has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Danaher used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Danaher has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Danaher's financial position?


Financial Position Analysis

Danaher is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Danaher's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Danaher's level of debt (32%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (12.9% vs 32% today).

Debt is well covered by operating cash flow (39.1%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 49.3x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1.1x debt.


Next Steps

Dividend

What is Danaher's current dividend yield, its reliability and sustainability?

0.49%

Expected Dividend Yield


Upcoming Dividend Payment

Purchase Danaher before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield and Payments Analysis

Danaher's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

Danaher's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

Danaher is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.

Danaher is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.


Current Payout to Shareholders

No need to calculate the sustainability of Danaher's dividends as it is not paying a notable one for United States of America.


Future Payout to Shareholders

No need to calculate the sustainability of Danaher's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Danaher's salary, the management and board of directors tenure and is there insider trading?

2.7yrs

Average management tenure


CEO

Tom Joyce (58yo)

5yrs

Tenure

US$15,361,041

Compensation

Mr. Thomas P. Joyce, Jr., also known as Tom, has been the Chief Executive Officer and President of Danaher Corp. since September 9, 2014. Mr. Joyce served as Executive Vice President of Danaher Corporation ...


CEO Compensation Analysis

Tom's remuneration is higher than average for companies of similar size in United States of America.

Tom's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.7yrs

Average Tenure

55yo

Average Age

The tenure for the Danaher management team is about average.


Board Age and Tenure

16.2yrs

Average Tenure

68yo

Average Age

The average tenure for the Danaher board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Steven Rales (68yo)

    Co-Founder & Chairman

    • Tenure: 35.7yrs
  • Dan Comas (55yo)

    Executive Vice President

    • Tenure: 0.7yrs
    • Compensation: US$6.85m
  • Dan Daniel (54yo)

    Executive Vice President

    • Tenure: 11.2yrs
    • Compensation: US$6.17m
  • Mitchell Rales (62yo)

    Co-Founder & Director

    • Tenure: 36.7yrs
  • Bob Lutz (61yo)

    Chief Accounting Officer & Senior VP

    • Tenure: 9.6yrs
  • Tom Joyce (58yo)

    CEO, President & Director

    • Tenure: 5yrs
    • Compensation: US$15.36m
  • Joakim Weidemanis (49yo)

    Executive Vice President

    • Tenure: 1.8yrs
    • Compensation: US$4.44m
  • Matt Gugino

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Rainer Blair (55yo)

    Executive Vice President

    • Tenure: 2.7yrs
    • Compensation: US$5.09m
  • Matt McGrew (47yo)

    CFO & Executive VP

    • Tenure: 0.7yrs

Board Members

  • Alan Spoon (68yo)

    Independent Director

    • Tenure: 20.7yrs
    • Compensation: US$279.82k
  • Steven Rales (68yo)

    Co-Founder & Chairman

    • Tenure: 35.7yrs
  • Donald Ehrlich (81yo)

    Lead Independent Director

    • Tenure: 0yrs
    • Compensation: US$329.82k
  • Walter Lohr (75yo)

    Independent Director

    • Tenure: 36.7yrs
    • Compensation: US$279.82k
  • Mitchell Rales (62yo)

    Co-Founder & Director

    • Tenure: 36.7yrs
  • John Schwieters (79yo)

    Independent Director

    • Tenure: 16.2yrs
    • Compensation: US$304.82k
  • Elias Zerhouni (68yo)

    Independent Director

    • Tenure: 10.7yrs
    • Compensation: US$279.82k
  • Linda Filler (59yo)

    Independent Director

    • Tenure: 13.8yrs
    • Compensation: US$294.82k
  • Tom Joyce (58yo)

    CEO, President & Director

    • Tenure: 5yrs
    • Compensation: US$15.36m
  • Teri List-Stoll (56yo)

    Independent Director

    • Tenure: 8yrs
    • Compensation: US$279.82k

Company Information

Danaher Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Danaher Corporation
  • Ticker: DHR.PRA
  • Exchange: NYSE
  • Founded: 1969
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$105.073b
  • Shares outstanding: 717.37m
  • Website: https://www.danaher.com

Number of Employees


Location

  • Danaher Corporation
  • 2200 Pennsylvania Avenue NW
  • Suite 800W
  • Washington
  • District Of Columbia
  • 20037
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DHRNYSE (New York Stock Exchange)YesCommon StockUSUSDNov 1969
DAPDB (Deutsche Boerse AG)YesCommon StockDEEURNov 1969
DHR *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNNov 1969
DHRSWX (SIX Swiss Exchange)YesCommon StockCHCHFNov 1969
0R2BLSE (London Stock Exchange)YesCommon StockGBUSDNov 1969
DHRCWBAG (Wiener Boerse AG)YesCommon StockATEURNov 1969
DHER34BOVESPA (Bolsa de Valores de Sao Paulo)BDR REPR 1/4 COM SHS USD0.01BRBRLJul 2015
DHR.PRANYSE (New York Stock Exchange)4.75 MND CV PFDUSUSDFeb 2019

Biography

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Life Sciences segment provides mass spectrometers; ce ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:54
End of Day Share Price2019/09/20 00:00
Earnings2019/06/28
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.